Save the date! Daiichi Sankyo will be at the Center for Healthcare Innovation’s Virtual Diversity Career Fair on June 27th. If you’re interested in new opportunities and learning about the innovative work we do—let’s connect. 🌟Registration is free! https://lnkd.in/gzeZqgB6 #hiring #recruiting
Daiichi Sankyo US
Pharmaceutical Manufacturing
Basking Ridge, NJ 184,791 followers
We create life-changing solutions for patients.
About us
At Daiichi Sankyo, we create essential medicine for longer, better lives. By uniting cutting edge science and technology with a genuine interest in people, we develop high quality, life changing solutions for the patients of today and tomorrow with great care and unwavering dedication. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need. For more information, please visit www.daiichisankyo.us. See our community guidelines here: https://bit.ly/3PYTqYr
- Website
-
https://daiichisankyo.us/
External link for Daiichi Sankyo US
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Basking Ridge, NJ
- Type
- Public Company
- Specialties
- Daiichi Sankyo, Inc. is a member of the Daiichi Sankyo group of companies and is focused on the development of oncology therapies and specialty medicines., Oncology, and Specialty Medicine
Locations
-
Primary
211 Mt. Airy Road Basking Ridge
Basking Ridge, NJ 07920, US
Employees at Daiichi Sankyo US
-
Jak (J. C.) DeTemple
Top Talent Executive Recruiter to the Biotech/Pharma Industry Leadership Superstars! Top Talent Sourcing Guru! Talent Acquisition & Retention…
-
Hayes Williams
Global Head of Data Governance at Daiichi Sankyo, Inc.
-
Desmon Swanston
-
Joseph Prikazsky
Pharma/Biotech Financial Professional
Updates
-
How can you help close the cancer screening gap? At Daiichi Sankyo US our BELIEVE BERG members have taken up the #BlackFamCan mantle and encourage all to be proactive in learning about risk factors, clinical trial opportunities, and advocacy for patients and caregivers in the black community—and you can too. #️⃣ Follow #ConversationsOnCancer. Through June 19th for National Black Family Cancer Awareness Week, the FDA is raising awareness of the crucial conversation needed to help reduce disparities. 📖 Read one woman’s story of building a black breast cancer community: https://bit.ly/4aHpvgQ 📣 Share #BlackFamCan resources: https://bit.ly/452HRry
-
Did you know #MensHealthWeek ends on #FathersDay? Check in on the fathers and father figures in your life and encourage them to prioritize their health today.
This content isn’t available here
Access this content and more in the LinkedIn app
-
"My dad was an inventor in fiber optics and telecom and even though it was difficult for me to understand exactly what he was working on, it was always clear that his mission was to come up with ideas, inventions and innovations that would improve people's lives." 🎧 Following in his father's footsteps, hear as Mark Chraplyvy, Executive Director, US Customer Insights & Market Analytics, shares his perspective on our collective role and responsibility in the process of healthcare #innovation. Follow along this #MensHealthWeek for more stories and inspiration.
-
Welcoming. Motivating. Inspiring. Engaging. These are just some of the words our 2024 #internship class used to describe their first week at Daiichi Sankyo US. Join us in welcoming our 2024 #intern class—from around the organization including R&D, procurement, communications, information technology, and many more. 💬 comment below with the best bit of advice you’ve received in your #career journey. #DSProud
-
What is your 1 PURPOSE? This year at the American Society of Clinical Oncology (ASCO) Congress we asked attendees to share the motivation behind their work. We hoped to inspire and unite us on under a common goal – to challenge the status quo in order to help the patients of tomorrow. What the global oncology community shared was more powerful than what we could have imagined. Scroll through the photos to see some of the captivating and moving quotes. #ASCO24
-
Breaking News: Today at a late-breaking oral session at the American Society of Clinical Oncology (ASCO) Congress results from the DESTINY-Breast06 phase 3 trial reporting progression-free survival data in certain previously treated patients with HER2 low or ultralow metastatic #BreastCancer will be presented. The DESTINY-Breast06 results have the potential to redefine the classification and treatment of metastatic breast cancer with new data in certain patients. Click the image to learn more.
-
“There are places which have nothing to do with you in terms of birthplace, yet, you go there and you have this explicit feeling of ‘this is home.’” German native and Daiichi Sankyo R&D leader Gerold Meinhardt, M.D., Ph.D., shares how he discovered his love of Japan and which elements of the Japanese leadership style he has adopted to lead high-performing teams in the development of innovative oncology medicines.
It All Started on a Trip to Japan
daiichisankyo.us
-
#BreakingNews: Today we announced topline results from the TROPION-Lung01 phase 3 trial evaluating our investigational #ADC in certain adult patients with previously treated locally advanced or metastatic #NSCLC (non-small cell lung cancer). Click the image for more information about these top line results and what it may mean for patients.
Press Releases - Daiichi Sankyo US
daiichisankyo.us
-
Today, we #HonorAndRemember the brave souls who gave their all for our freedoms. Their legacies are powerful reminders to meet every day with passion and purpose to continue making a positive impact—in our communities and around the world. #MemorialDay